Search results
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 5 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
3 Ultra-High-Yield Dividend Stocks Billionaires Are Sinking Their Teeth Into
Motley Fool via Yahoo Finance· 5 days agoThis makes the single-digit forward price-to-earnings (P/E) ratios and high-yields attached to...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
Moderna stock is lone omen of bird flu pandemic
Reuters· 9 hours agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
What's Driving ICU Medical Inc's Surprising 15% Stock Rally?
Guru Focus· 12 hours agoICU Medical Inc (ICUI), a prominent player in the medical devices and instruments industry, has recently witnessed a notable uptick in its stock performance. Ov
Dividend stocks can help lower your risk. Many are bargains right now.
MarketWatch via Yahoo Finance· 5 days agoHD — the fund’s 10th largest U.S. stockholding — is another interesting example. If you bought the ...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 8 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade |...
The Motley Fool· 2 days agoThe S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 6 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward ...